42 related articles for article (PubMed ID: 3211917)
1. antinociceptive properties of [D-Ala2, NMPhe4, Gly-ol]-enkephalin (DAGO) in tests of acute and tonic pain in mice.
Mulvaney SA; Sheldon RJ; Cowan A; Porreca F
Proc West Pharmacol Soc; 1988; 31():285-6. PubMed ID: 3211917
[No Abstract] [Full Text] [Related]
2. Evidence for opioid receptor interactions in vivo.
Heyman JS; Porreca F
Proc West Pharmacol Soc; 1988; 31():287-9. PubMed ID: 2850560
[No Abstract] [Full Text] [Related]
3. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
[TBL] [Abstract][Full Text] [Related]
4. Central opiate mu-receptor-mediated suppression of tissue protein synthesis.
Hashiguchi Y; Molina PE; Dorton S; McNurlan MA; Garlick PJ; Reddy D; Abumrad NN
Am J Physiol; 1997 Sep; 273(3 Pt 2):R920-7. PubMed ID: 9321868
[TBL] [Abstract][Full Text] [Related]
5. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
6. EEG and behavioral effects of morphine, enkephalins and derivatives administered into the lateral cerebral ventricles of rats and rabbits.
Aloisi F; Scotti De Carolis A; Longo V
Pharmacol Res Commun; 1980 May; 12(5):467-77. PubMed ID: 7443754
[No Abstract] [Full Text] [Related]
7. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
8. Intracerebroventricular analgesia enhanced by intrathecal (IT) dynorphin A(1-17) antibody.
Fujimoto J; Arts KS; Rady J; Tseng L
Prog Clin Biol Res; 1990; 328():433-6. PubMed ID: 1968272
[No Abstract] [Full Text] [Related]
9. [Opiate-ergic mechanisms of the cardiotropic effect of acute cooling].
Afanas'ev SA; Alekseeva ED; Lishmanov IuB
Biull Eksp Biol Med; 1994 Dec; 118(12):582-4. PubMed ID: 7703448
[No Abstract] [Full Text] [Related]
10. Evaluation of the analgesic activity of morphine, enkephalins and their synthetic analogues.
Aloisi F; Scotti de Carolis A; Longo VG
Isr J Med Sci; 1982 Jan; 18(1):183-6. PubMed ID: 7068340
[TBL] [Abstract][Full Text] [Related]
11. Nitrocinnamoyl and chlorocinnamoyl derivatives of dihydrocodeinone: in vivo and in vitro characterization of mu-selective agonist and antagonist activity.
McLaughlin JP; Hill KP; Jiang Q; Sebastian A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1999 Apr; 289(1):304-11. PubMed ID: 10087018
[TBL] [Abstract][Full Text] [Related]
12. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of nitric oxide synthase enhances antinociception mediated by mu, delta and kappa opioid receptors in acute and prolonged pain in the rat spinal cord.
Machelska H; Labuz D; Przewłocki R; Przewłocka B
J Pharmacol Exp Ther; 1997 Aug; 282(2):977-84. PubMed ID: 9262366
[TBL] [Abstract][Full Text] [Related]
14. Opioid peptides selective for receptor types modulate cocaine-induced behavioral responses in mice.
Ukai M; Mizutani M; Kameyama T
Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Jun; 14(3):153-9. PubMed ID: 7941780
[TBL] [Abstract][Full Text] [Related]
15. Role of intracellular calcium in modification of mu and delta opioid receptor-mediated antinociception by diabetes in mice.
Ohsawa M; Nagase H; Kamei J
J Pharmacol Exp Ther; 1998 Aug; 286(2):780-7. PubMed ID: 9694934
[TBL] [Abstract][Full Text] [Related]
16. Antinociceptive profile of biphalin, a dimeric enkephalin analog.
Horan PJ; Mattia A; Bilsky EJ; Weber S; Davis TP; Yamamura HI; Malatynska E; Appleyard SM; Slaninova J; Misicka A
J Pharmacol Exp Ther; 1993 Jun; 265(3):1446-54. PubMed ID: 8389867
[TBL] [Abstract][Full Text] [Related]
17. [Inhibitory effects of three opioid receptor agonists on synaptic transmission].
Yuan XR
Zhongguo Yao Li Xue Bao; 1996 May; 17(3):278-80. PubMed ID: 9812758
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of attenuation of morphine antinociception by chronic treatment with L-arginine.
Bhargava HN; Bian JT; Kumar S
J Pharmacol Exp Ther; 1997 May; 281(2):707-12. PubMed ID: 9152376
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats.
Pfeiffer A; Feuerstein G; Kopin IJ; Faden AI
J Pharmacol Exp Ther; 1983 Jun; 225(3):735-41. PubMed ID: 6306217
[TBL] [Abstract][Full Text] [Related]
20. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
